Inogen (INGN) EBITDA Margin Growth (1y) (2014 - 2026)
Inogen (INGN) EBITDA Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 241.00 |
| 10 | Inogen | 170.77 Mn | 60.59 Mn | 37.86 Mn | -166.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -166.00 |
| Dec 31, 2025 | 283.00 |
| Sep 30, 2025 | 107.00 |
| Jun 30, 2025 | 132.00 |
| Mar 31, 2025 | 1,155.00 |
| Dec 31, 2024 | 2,397.00 |
| Sep 30, 2024 | 4,687.00 |
| Jun 30, 2024 | 611.00 |
| Mar 31, 2024 | 951.00 |
| Dec 31, 2023 | 2,821.00 |
| Sep 30, 2023 | -4,588.00 |
| Jun 30, 2023 | -1,129.00 |
| Mar 31, 2023 | -1,347.00 |
| Dec 31, 2022 | -6,031.00 |
| Sep 30, 2022 | -1,764.00 |
| Jun 30, 2022 | -1,427.00 |
| Mar 31, 2022 | -1,445.00 |
| Dec 31, 2021 | 138.00 |
| Sep 30, 2021 | 1,082.00 |
| Jun 30, 2021 | 1,507.00 |